Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune- mediated motor disorder that accounts for approximately 20% of apparently undiagnosed neuropathies referred to tertiary care centers. Although their contributions are unclear, it is thought that both cellular and humoral immune mechanisms play a part in the etiology of CIDP. Improvement has been noted in CIDP patients previously unresponsive to other therapies with IVIG. This treatment is easier and less risky than customary treatments.
Showing the most recent 10 out of 577 publications